← Leaderboards
Michael Gordon
Indiana Univ-Purdue Univ At Indianapolis
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Patrick J Loehrer$17,498,162
- Melissa L Fishel$7,092,542
- Kenneth P Nephew$7,005,060
- David A Williams$57,290,422
- Mark R. Kelley$16,203,613
Others in their field
Top investigators on “Drug Administration Rate /Duration”
- Michael A Kass · Washington University$9,081,282
- Jane Ryan · Biota Scientific Management$5,628,310
- Peter Scott Heeger · Case Western Reserve University$4,835,821
- Richard L Schilsky · University Of Chicago$4,312,507
- Christopher C. Whalen · Case Western Reserve University$3,692,379
- Stanley Fahn · Columbia University Health Sciences$3,010,901
Research focus
Drug Administration Rate /DurationHuman SubjectClinical ResearchMetastasisHuman Therapy EvaluationRenal Cell CarcinomaDrug Administration RoutesInterferon AlphaInterleukin 2Neoplasm /Cancer ImmunotherapyMelanomaPaclitaxelNeoplasm /Cancer Chemotherapy
Grant awards (14)
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2002 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2002 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2001 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2001 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2000 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2000 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
WEEKLY LOW DOSE TAXOTERE IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2000 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2000 · RR
HIGH DOSE IL2 VS SUBCUTANEOUS IL2/IFN IN METASTATIC RENAL CELL CARCINOMA$0
M01 · FY2000 · RR